Delivery Order SPE2DB20D3101-SPE2DB23FRCC8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,931.70 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $2,206.07 delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price and is set to be completed by March 20, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,961.38 delivery order contract is for the supply of Brilinta 90 mg tablets, a cardiovascular medication. The contract has a firm fixed price pricing type and a completion date of November 16, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,069.60 for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,705.56 firm-fixed-price delivery order is for the supply of BRILINTA 60 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of November 15, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,438.82 for the supply of BRILINTA 60 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that procures medical supplies and pharmaceuticals for military and veterans' healthcare programs. The contract is a firm fixed-price arrangement and was not designated as a set-aside for specific business types....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4,564,450,935 units of BRILINTA 90 MG Tablets, a prescription cardiovascular medication, with a ceiling value of $6,596.35. The contract is a firm-fixed-price arrangement with a period of performance through May 1, 2024. This contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of BRILINTA 60 MG TABLET 60S. The $1,086.68 firm fixed-price delivery order has a completion date of July 27, 2023 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Brilinta 90 mg tablets for the Defense Logistics Agency (DLA). The award, valued at $1,129.24, is a firm-fixed price Delivery Order with an ultimate completion date of April 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,274.53 firm-fixed-price delivery order covers the supply of Brilinta 90 mg tablets, a medication used to treat cardiovascular conditions. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRCC8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,697.53 firm fixed-price contract is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. This contract is not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop Support Medical that runs through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/7/23 |